| mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
1e-07 |
| mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
4e-07 |
| mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
5e-07 |
| mRNA |
thapsigargin |
gCSI |
pan-cancer |
AAC |
0.28 |
6e-07 |
| mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
0.25 |
7e-07 |
| mRNA |
FK866 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-06 |
| mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
1e-06 |
| mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
0.26 |
2e-06 |
| mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
4e-06 |
| mRNA |
Ispinesib Mesylate |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
4e-06 |